Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 521: Norepinephrine is metabolized by which of the following enzymes?

A. COMT
B. MAO
C. Both COMT and MAO (Correct Answer)
D. Neither COMT nor MAO

Explanation: **Explanation:** Norepinephrine (NE), a key catecholamine neurotransmitter, is metabolized by two primary enzymes: **Monoamine Oxidase (MAO)** and **Catechol-O-Methyltransferase (COMT)** [1]. 1. **MAO (Monoamine Oxidase):** Located primarily on the outer mitochondrial membrane of neurons and other cells (liver, gut), MAO is responsible for the **oxidative deamination** of norepinephrine [1]. It acts mainly on the NE present within the nerve terminal. 2. **COMT (Catechol-O-Methyltransferase):** Found in the cytosol, particularly in the liver and kidneys, COMT performs **O-methylation**. It primarily metabolizes circulating catecholamines and those in the extraneuronal space. The final major metabolic end-product of norepinephrine and epinephrine metabolism is **Vanillylmandellic Acid (VMA)**, which is excreted in the urine [1]. **Analysis of Options:** * **Option A & B:** These are incorrect because they are incomplete. While both enzymes act on NE, they do not act in isolation; they work sequentially or independently to degrade catecholamines. * **Option D:** This is incorrect as NE is not significantly degraded by other pathways like hydrolysis; it relies almost entirely on MAO and COMT for termination of action (alongside reuptake) [1, 2]. **NEET-PG High-Yield Pearls:** * **Termination of Action:** The primary mechanism for terminating the action of NE at the synaptic cleft is **reuptake (Uptake-1)** into the presynaptic neuron, *not* enzymatic degradation [1, 2]. * **VMA Levels:** Urinary VMA is a critical diagnostic marker for **Pheochromocytoma** (a catecholamine-secreting tumor). * **MAO Subtypes:** MAO-A preferentially metabolizes NE, Serotonin, and Epinephrine, while MAO-B acts primarily on Dopamine. * **Metanephrines:** Intermediate metabolites (Normetanephrine and Metanephrine) are often more sensitive markers for diagnosing adrenergic tumors than VMA.

Question 522: In which of the following poisonings, pralidoxime is ineffective?

A. Organophosphorus
B. Carbaryl (Correct Answer)
C. Both of the above
D. None of the above

Explanation: ### Explanation The correct answer is **Carbaryl (Option B)**. **1. Why Pralidoxime is ineffective in Carbaryl poisoning:** Carbaryl belongs to the **Carbamate** class of insecticides. Carbamates inhibit the enzyme acetylcholinesterase (AChE) by carbamoylating the esteratic site. Unlike Organophosphates (OPs), the bond formed between carbamates and AChE is **reversible** and does not undergo "aging." Pralidoxime (2-PAM) is a cholinesterase reactivator. It works by displacing the phosphate group from the enzyme. In carbamate poisoning, pralidoxime is not only unnecessary (due to the spontaneous dissociation of the carbamate-enzyme complex) but is specifically **contraindicated** in Carbaryl poisoning. This is because pralidoxime has weak anticholinesterase activity itself and can exacerbate the enzyme inhibition, potentially worsening the clinical toxicity. **2. Analysis of Incorrect Options:** * **Option A (Organophosphorus):** OPs cause irreversible inhibition of AChE by phosphorylation. Pralidoxime is the drug of choice (alongside Atropine) because it can dephosphorylate the enzyme, provided it is administered before "aging" (permanent covalent bonding) occurs. * **Option C & D:** These are incorrect based on the specific pharmacological contraindication of oximes in carbamate toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **"Aging":** This phenomenon occurs only with Organophosphates, not Carbamates. Once aging occurs, oximes are no longer effective. * **Management Rule:** In Carbamate poisoning, use **Atropine only**. Avoid Oximes. * **Exception:** Some texts suggest oximes may be used in *mixed* OP-Carbamate poisoning, but for exam purposes, they are ineffective/contraindicated for Carbaryl. * **Mnemonic:** Carbamates are "Reversible," OPs are "Irreversible."

Question 523: Pseudocholinesterase is synthesized by which organ?

A. Liver (Correct Answer)
B. Plasma
C. Muscle end plate
D. Nerve ending

Explanation: ### Explanation **Correct Answer: A. Liver** **Underlying Medical Concept:** Cholinesterases are enzymes that hydrolyze acetylcholine. There are two main types: **True Cholinesterase** (Acetylcholinesterase) and **Pseudocholinesterase** (Butyrylcholinesterase or Plasma cholinesterase). While True Cholinesterase is found at neural sites, Pseudocholinesterase is a glycoprotein **synthesized primarily in the liver** and secreted into the plasma. It has no known physiological function at the synapse but plays a critical role in metabolizing exogenous drugs like Succinylcholine, Mivacurium, and Procaine. **Analysis of Incorrect Options:** * **B. Plasma:** This is the primary *location* where the enzyme functions, but it is not the site of *synthesis*. Confusing the site of action with the site of production is a common examiner trap. * **C. Muscle end plate:** This is the site for **True Cholinesterase**. It is required here for the rapid termination of signal transmission by breaking down acetylcholine released from motor neurons. * **D. Nerve ending:** Similar to the muscle end plate, cholinergic nerve endings (synaptic clefts) contain True Cholinesterase to ensure discrete, non-repetitive nerve impulses. **Clinical Pearls for NEET-PG:** 1. **Succinylcholine Apnea:** Patients with a genetic deficiency of Pseudocholinesterase or liver disease (reduced synthesis) cannot metabolize Succinylcholine efficiently, leading to prolonged muscle paralysis and respiratory failure. 2. **Dibucaine Number:** This test is used to identify atypical Pseudocholinesterase. A low Dibucaine number indicates an abnormal enzyme that cannot hydrolyze Succinylcholine. 3. **Organophosphate Poisoning:** Both enzymes are inhibited. However, Pseudocholinesterase levels (Plasma levels) fall faster than RBC cholinesterase, making it a sensitive early marker for exposure.

Question 524: Pilocarpine reduces the intraocular pressure in persons with closed-angle glaucoma by:

A. Reducing aqueous humor secretion
B. Contracting the iris sphincter muscle
C. Increasing aqueous humor outflow (Correct Answer)
D. Relaxing the ciliary muscle

Explanation: ### Explanation **Mechanism of Action (The Correct Answer)** Pilocarpine is a direct-acting cholinergic agonist (muscarinic agonist). In **closed-angle glaucoma**, the primary pathology is the mechanical obstruction of the trabecular meshwork by the peripheral iris. * Pilocarpine stimulates the **M3 receptors** on the **iris sphincter muscle**, causing **miosis** (pupillary constriction). * This contraction pulls the iris away from the trabecular meshwork, physically opening the "angle." * Consequently, it facilitates the drainage of aqueous humor through the Canal of Schlemm, thereby **increasing aqueous humor outflow** and rapidly reducing intraocular pressure (IOP). **Analysis of Incorrect Options** * **A. Reducing aqueous humor secretion:** This is the mechanism of Beta-blockers (e.g., Timolol), Alpha-2 agonists (e.g., Brimonidine), and Carbonic anhydrase inhibitors (e.g., Acetazolamide). * **B. Contracting the iris sphincter muscle:** While Pilocarpine *does* cause this, it is the **means** to an end. The question asks how it reduces IOP; the reduction is specifically due to the resulting increase in outflow, not the miosis itself. * **D. Relaxing the ciliary muscle:** Pilocarpine actually **contracts** the ciliary muscle (causing accommodation for near vision/cyclotonia). Relaxation of the ciliary muscle is caused by anticholinergics (e.g., Atropine), which can worsen closed-angle glaucoma. **NEET-PG High-Yield Pearls** * **Drug of Choice:** Pilocarpine is the emergency drug of choice for **acute angle-closure glaucoma** to quickly lower IOP before definitive surgery (iridotomy). * **Adverse Effects:** It can cause "brow ache" (due to ciliary spasm) and retinal detachment in predisposed individuals. * **Open-angle Glaucoma:** In open-angle glaucoma, Pilocarpine works by contracting the ciliary muscle, which stretches the trabecular meshwork to increase drainage. * **Mnemonic:** **P**ilocarpine = **P**ulls the iris away from the angle.

Question 525: Which of the following drugs is useful in the prophylaxis of motion sickness?

A. Hyoscine (Correct Answer)
B. Metoclopramide
C. Prochlorperazine
D. Ondansetron

Explanation: **Hyoscine (Scopolamine)** is the drug of choice for the **prophylaxis of motion sickness** [1], [2], [3]. The underlying mechanism involves the vestibular apparatus in the inner ear, which sends signals to the vomiting center via cholinergic (muscarinic) and histaminergic pathways. Hyoscine is a potent **M1 muscarinic antagonist** [3], [4] that acts on the vestibular nuclei and the Chemoreceptor Trigger Zone (CTZ), effectively blocking these excitatory impulses. For maximum efficacy, it must be administered *before* the journey (prophylactically), often via a transdermal patch applied behind the ear (pinna) [1], [2]. **Analysis of Incorrect Options:** * **Metoclopramide:** A D2 receptor antagonist and 5-HT4 agonist [3], [4]. While it is a potent prokinetic used for gastroparesis and post-operative nausea, it is **ineffective** in motion sickness because dopamine receptors do not play a primary role in the vestibular pathway [3]. * **Prochlorperazine:** A dopamine (D2) antagonist belonging to the phenothiazine class [3]. It is primarily used for vertigo (Meniere’s disease) and drug-induced vomiting but is less effective than anticholinergics for motion sickness [3]. * **Ondansetron:** A 5-HT3 receptor antagonist [4]. It is the gold standard for **chemotherapy-induced nausea and vomiting (CINV)** and post-operative vomiting but has no role in motion sickness [3]. **High-Yield NEET-PG Pearls:** * **Best route for Hyoscine:** Transdermal patch (delivers drug for 3 days) [1], [2]. * **Alternative for Motion Sickness:** H1 antihistaminics with strong anticholinergic properties (e.g., **Promethazine, Cyclizine, Dimenhydrinate**) [1], [3], [4]. * **Key Side Effect:** Sedation and dry mouth (typical anticholinergic profile) [1], [3]. * **Cyclizine** is specifically preferred in motion sickness for pregnant women (though morning sickness is usually managed with Doxylamine).

Question 526: Which of the following physiological activities is NOT mediated through β2 adrenergic receptors?

A. Stimulation of lipolysis (Correct Answer)
B. Increased hepatic gluconeogenesis
C. Increased muscle glycogenolysis
D. Smooth muscle relaxation

Explanation: **Explanation:** The correct answer is **A. Stimulation of lipolysis**. **1. Why Option A is correct:** Lipolysis (the breakdown of lipids into fatty acids) is primarily mediated by **$\beta_3$ adrenergic receptors** (and to a lesser extent $\beta_1$ receptors) located in adipose tissue. While $\beta_2$ receptors are widely distributed, they do not play a significant role in the stimulation of lipolysis. **2. Why the other options are incorrect:** * **B & C (Metabolic effects):** $\beta_2$ receptors are the primary mediators of catecholamine-induced hyperglycemia. They stimulate **hepatic gluconeogenesis** and **glycogenolysis** (Option B) as well as **muscle glycogenolysis** (Option C). This provides immediate energy substrates during a "fight or flight" response. * **D (Smooth muscle relaxation):** The hallmark of $\beta_2$ receptor activation is the relaxation of smooth muscles. This includes **bronchodilation** (lungs), **vasodilation** (skeletal muscle blood vessels), and **uterine relaxation** (tocolysis). **High-Yield NEET-PG Pearls:** * **$\beta_1$ Location:** Primarily Heart (Inotropy/Chronotropy) and Juxtaglomerular cells (Renin release). Remember: *"1 Heart."* * **$\beta_2$ Location:** Lungs, Blood vessels, GI tract, Bladder, Uterus, and Liver. Remember: *"2 Lungs."* * **$\beta_3$ Location:** Adipose tissue (Lipolysis) and Detrusor muscle (Mirabegron is a $\beta_3$ agonist used for overactive bladder). * **Potassium Shift:** $\beta_2$ stimulation promotes the uptake of potassium into skeletal muscles (via Na+/K+ ATPase), which can lead to **hypokalemia**. This is why Salbutamol is used in the emergency management of hyperkalemia.

Question 527: Dry skin seen due to excess dosage of datura is due to which of the following mechanisms?

A. Vasodilatation
B. Absence of sweating (Correct Answer)
C. Central action
D. Change in basal metabolic rate

Explanation: The correct answer is **B. Absence of sweating**. Datura contains belladonna alkaloids, primarily **Atropine** and **Scopolamine**, which act as competitive antagonists at **Muscarinic (M) receptors** [3, 4]. 1. **Mechanism:** Sweat glands are innervated by sympathetic cholinergic fibers. These fibers release acetylcholine, which acts on **M3 receptors** to stimulate sweating. Datura alkaloids block these M3 receptors, leading to a complete suppression of sweat production (**Anhidrosis**). Since evaporation of sweat is the primary mechanism for heat loss, the skin becomes characteristically **dry and hot** [1, 2]. 2. **Why other options are wrong:** * **Vasodilatation (A):** While atropine poisoning causes "Atropine Flush" (cutaneous vasodilation), this makes the skin *red*, not dry. The dryness is specifically a secretory failure. * **Central action (C):** While Datura causes CNS effects (delirium, hallucinations), the dry skin is a peripheral effect on the effector organ (sweat glands). * **Change in BMR (D):** Datura does not significantly alter the basal metabolic rate; the rise in body temperature is due to the inability to dissipate heat (hyperpyrexia), not increased heat production [1]. **NEET-PG High-Yield Pearls:** * **The Mnemonic for Atropine/Datura Poisoning:** * *Dry as a bone* (Anhidrosis/Dry skin) [2] * *Red as a beet* (Cutaneous vasodilation) * *Blind as a bat* (Mydriasis/Cycloplegia) [2] * *Hot as a hare* (Hyperpyrexia) [1] * *Mad as a hatter* (Delirium/Psychosis) * **Antidote of choice:** **Physostigmine** (a tertiary amine carbamate that crosses the Blood-Brain Barrier). * **Clinical Sign:** "Dry skin" is a crucial differentiating feature between Datura poisoning and OP poisoning (where skin is moist/diaphoretic).

Question 528: Which of the following is NOT an action of epinephrine when administered intravenously in a high dose?

A. Increases liver glycogenolysis
B. Causes bronchiolar constriction (Correct Answer)
C. Evokes extrasystoles in the heart
D. Produces restlessness and anxiety

Explanation: **Explanation:** Epinephrine (Adrenaline) is a potent agonist at both **alpha (α₁, α₂)** and **beta (β₁, β₂, β₃)** adrenergic receptors. The question asks for the action that is NOT produced by epinephrine. **1. Why Option B is correct:** Epinephrine acts on **β₂ receptors** located in the bronchial smooth muscle. Activation of these receptors leads to **bronchodilation**, not constriction. This is why epinephrine is a life-saving drug in acute bronchial asthma and anaphylaxis. Bronchoconstriction is typically mediated by the parasympathetic system (M₃ receptors) or inflammatory mediators like histamine and leukotrienes. **2. Why the other options are incorrect:** * **Option A (Liver glycogenolysis):** Epinephrine stimulates **β₂ and α₁ receptors** in the liver, promoting the breakdown of glycogen into glucose. This increases blood glucose levels to provide energy during "fight or flight" situations. * **Option C (Extrasystoles):** Through **β₁ receptors** in the myocardium, epinephrine increases heart rate (chronotropy) and excitability. High doses can trigger ectopic foci, leading to extrasystoles or arrhythmias. * **Option D (Restlessness and anxiety):** Although epinephrine crosses the blood-brain barrier poorly, high IV doses cause significant peripheral physiological changes (palpitations, tremors) and some central stimulation, manifesting as anxiety, restlessness, and apprehension. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC):** Epinephrine (1:1000 IM) is the DOC for **Anaphylactic Shock**. * **Vasomotor Reversal of Dale:** If an α-blocker (e.g., phentolamine) is given before epinephrine, the α-mediated vasoconstriction is blocked, leaving only β₂-mediated vasodilation, causing a fall in BP instead of a rise. * **Metabolism:** Epinephrine is metabolized by **MAO** and **COMT**; the end product excreted in urine is **Vanillylmandellic acid (VMA)**.

Question 529: Which statement is true regarding dobutamine?

A. Dobutamine decreases peripheral resistance. (Correct Answer)
B. Dobutamine acts on D1 and D2 receptors.
C. Dobutamine decreases kidney circulation.
D. Dobutamine has no effect on coronary circulation.

Explanation: **Explanation:** Dobutamine is a synthetic catecholamine primarily used as a positive inotropic agent. Its pharmacological profile is unique due to its action on multiple adrenergic receptors. **1. Why Option A is correct:** Dobutamine is a relatively selective **$\beta_1$-agonist**, but it also possesses activity at $\beta_2$ and $\alpha_1$ receptors. While its $\beta_1$ effect increases cardiac output, its **$\beta_2$-agonist activity** leads to vasodilation in the skeletal muscle vascular bed. This results in a **decrease in total peripheral resistance (TPR)**. Although it has some $\alpha_1$ agonist activity (which causes vasoconstriction), the $\beta_2$ effect usually predominates or balances it out, leading to a net reduction in afterload. **2. Why the other options are incorrect:** * **Option B:** Unlike dopamine, dobutamine **does not act on Dopaminergic (D1 or D2) receptors**. It is purely an adrenergic agonist. * **Option C:** Dobutamine generally **increases renal blood flow**. This is not due to direct D1 stimulation (like dopamine), but rather a secondary effect of increased cardiac output and improved systemic hemodynamics. * **Option D:** Dobutamine **increases coronary blood flow** due to increased cardiac work and secondary metabolic vasodilation, as well as direct $\beta_2$ effects on coronary vessels. **Clinical Pearls for NEET-PG:** * **Drug of Choice:** Dobutamine is the preferred inotrope for **Cardiogenic Shock** (without severe hypotension) and **Acute Decompensated Heart Failure**. * **Dobutamine Stress Echo:** Used to diagnose ischemic heart disease in patients unable to exercise; it increases myocardial oxygen demand to reveal wall motion abnormalities. * **Isomeric property:** The (+)-isomer is a powerful $\beta$ agonist, while the (-)-isomer is an $\alpha_1$ agonist. In clinical racemic mixtures, the $\beta$ effects predominate.

Question 530: Dobutamine differs from dopamine in which of the following ways?

A. It has good blood-brain barrier penetrability.
B. It causes pronounced tachycardia.
C. It does not activate adrenergic beta receptors.
D. It does not activate peripheral dopaminergic receptors. (Correct Answer)

Explanation: The primary pharmacological difference between Dobutamine and Dopamine lies in their receptor selectivity, specifically regarding **dopaminergic (D1 and D2) receptors.** **1. Why Option D is Correct:** Dopamine is a precursor to norepinephrine [2] and acts on **D1 receptors** (causing renal and mesenteric vasodilation), **β1 receptors** (increasing heart rate/contractility), and **α1 receptors** (causing vasoconstriction at high doses). [1] In contrast, **Dobutamine** is a synthetic catecholamine that acts primarily as a **selective β1 agonist**. [3] It has **no significant activity at peripheral dopaminergic receptors**, [3] meaning it does not cause the "renal dose" vasodilation traditionally associated with dopamine. **2. Analysis of Incorrect Options:** * **Option A:** Both drugs are polar catecholamines and have **poor blood-brain barrier penetrability**. They do not produce significant CNS effects. * **Option B:** While both can cause tachycardia, Dobutamine is specifically noted for being **more inotropic than chronotropic**. [3] It increases cardiac output with relatively less tachycardia compared to dopamine or isoproterenom. [3] * **Option C:** This is incorrect because Dobutamine is a **potent β1 receptor agonist**; this is its primary mechanism of action for treating cardiogenic shock. **3. High-Yield Clinical Pearls for NEET-PG:** * **Dobutamine** is the drug of choice for **Cardiogenic Shock** because it increases cardiac output without significantly increasing myocardial oxygen demand (due to less tachycardia). * **Dopamine** exhibits **dose-dependent effects**: Low dose (D1 - Renal), Medium dose (β1 - Cardiac), High dose (α1 - Vasoconstriction). [1] * **Fenoldopam** is a selective D1 agonist used in hypertensive emergencies to maintain renal perfusion. * **Isomerism:** Dobutamine is a racemic mixture; the (+) isomer is a β-agonist, while the (-) isomer is an α1-agonist, but the net clinical effect is predominantly β1 stimulation. [3]

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free